- Dr Fiona Dignan is a consultant in haemato-oncology and has been clinical lead for haematology at Manchester Royal Infirmary since 2015. She undertook her haematology training…
- Graft vs Host Disease (GvHD) is a common complication for many patients during their recovery after a stem cell transplant. It’s caused by small differences between the new immune…
- Journalist, writer and broadcaster Carl Anka blogs honestly about his fears and concerns around donating and how he overcame them to do an 'amazing' and 'selfless' act. My…
- Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
- Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the…
- After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand…
- After being diagnosed with essential thrombocythemia (ET), Colin’s blood disorder developed into myelofibrosis, a rare type of bone cancer. Here, he talks about his two stem cell…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the enormous potential of cord blood as a starting material in research to…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the importance of where starting materials come from and how the Anthony…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.